Human intestinal P-glycoprotein activity estimated by the model substrate digoxin

By Larsen U. L.   Olesen Hyldahl   Nyvold Guldborg   Eriksen J.   Jakobsen P.   Østergaard M.   Autrup H.   Andersen V.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 2, 2007-01 ,pp. : 123-134

Informa Healthcare

Access to resources Recommend Favorite

Determination and Prediction of P-Glycoprotein and Multidrug-Resistance-Related Protein Expression in Breast Cancer with Double-Phase Technetium-99m Sestamibi Scintimammography

By  

Oncology, Vol. 70, Iss. 6, 2007-02 ,pp. : 403-410

Karger

Access to resources Recommend Favorite

Effects of renal impairment on the pharmacokinetics of orally administered deferiprone

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 82, Iss. 4, 2016-10 ,pp. : 994-1001

John Wiley & Sons Inc

Access to resources Recommend Favorite

P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells

By Navarro Gemma   Sawant Rupa R   Biswas Swati   Essex Sean   Tros de Ilarduya Conchita   Torchilin Vladimir P  

Nanomedicine, Vol. 7, Iss. 1, 2012-01 ,pp. : 65-78

Future Medicine

Access to resources Recommend Favorite

Pharmacoresistance in Epilepsy: A Pilot PET Study with the P‐Glycoprotein Substrate R‐[¹¹C]verapamil

By  

EPILEPSIA, Vol. 48, Iss. 9, 2007-09 ,pp. : 1774-1784

John Wiley & Sons Inc

Access to resources Recommend Favorite